milrinone has been researched along with thromboxane a2 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gill, J; Jeremy, JY; Mikhailidis, D | 1 |
Barradas, MA; Jagroop, A; Jeremy, JY; Mikhailidis, DP; O'Donoghue, S | 1 |
Levy, JH; Salmenperä, M | 1 |
Ahmad, A; Floten, S; Furnary, A; Gately, H; He, GW; Starr, A; Swanson, J; Wood, J; Yang, CO | 1 |
He, GW; Yang, CQ | 1 |
5 other study(ies) available for milrinone and thromboxane a2
Article | Year |
---|---|
Effect of milrinone on thromboxane A2 synthesis, cAMP phosphodiesterase and 45Ca2+ uptake by human platelets.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Calcium; Drug Interactions; Humans; Iloprost; In Vitro Techniques; Milrinone; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Pyridones; Thromboxane A2 | 1993 |
Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Blood Platelets; Calcimycin; Cells, Cultured; Humans; Indomethacin; Milrinone; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Serotonin; Thromboxane A2 | 1993 |
The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Humans; Mammary Arteries; Milrinone; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Female; Humans; In Vitro Techniques; Male; Mammary Arteries; Milrinone; Nitroglycerin; Phosphodiesterase Inhibitors; Potassium; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 3',5'-Cyclic-AMP Phosphodiesterases; Arteries; Cardiovascular Agents; Coronary Artery Bypass; Cyclic Nucleotide Phosphodiesterases, Type 3; Endothelin-1; Female; Humans; In Vitro Techniques; Male; Milrinone; Phenylephrine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents | 1996 |